It’s hard to stand out in the Bay Area life science ecosystem because the number and quality of the companies is so high. Needless to say, Bikanta is proud to be 1 of 4 companies nominated for Diagnostic Startup of the Year for the 2015 QB3 Awards!
Entrepreneurs and visionary investors have made the San Francisco Bay Area a world-leading center of the life science industry. Extraordinary individuals and teams are working to solve our greatest challenges: the needs for abundant energy, a clean environment, and better healthcare. With the support of JPMorgan Chase, QB3 is recognizing the highest level of achievement in life science entrepreneurship in the San Francisco Bay Area with awards and nominees in 10 categories:
- Diagnostics Startup of the Year
- Bikanta
- Diassess
- Mindera
- Privail
- Medical Device Startup of the Year
- ChemoFilter
- Ocular Dynamics
- Pelvalon
- Twelve
- Synthetic Biology Startup of the Year
- Bolt Threads
- Industrial Microbes
- Lygos
- Zymergen
- Therapeutics Startup of the Year
- 4D Molecular Therapeutics
- Neurona
- Nurix
- Principia
- Early-Stage Investor of the Year
- The Column Group
- Dolby Family Ventures
- Five Prime Ventures
- U.S. Venture Partners
- Most Admired Company
- BioMarin
- Celgene
- Gilead
- Medivation
- Most Intriguing Company
- Calico Labs
- Cibiem
- CytomX
- Xcell Biosciences
- Groundbreaking Science
- Caribou Biosciences
- Circle Pharma
- Magnetic Insight
- ViewPoint Therapeutics
The awards ceremony is the evening of Tuesday, October 27, at the California Academy of Sciences in Golden Gate Park. Wish Bikanta luck!
